Hospira, Inc., a Pfizer company, is voluntarily recalling 8 lots of Hospira’s Daptomycin for Injection 500 mg, Lyophilized Powder For Solution, Single Dose Vial (NDC 0409-0106-01) to the Hospital/Retail level. The product is being recalled due to adverse event reports indicative of infusion reactions.
View the full article from the FDA.
Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyop
No replies to this topic
0 user(s) are reading this topic
0 members, 0 guests, 0 anonymous users